196 related articles for article (PubMed ID: 28161666)
1. Cellular internalization and transport of biodegradable polyester dendrimers on a model of the pulmonary epithelium and their formulation in pressurized metered-dose inhalers.
Heyder RS; Zhong Q; Bazito RC; da Rocha SRP
Int J Pharm; 2017 Mar; 520(1-2):181-194. PubMed ID: 28161666
[TBL] [Abstract][Full Text] [Related]
2. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
3. Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.
Bharatwaj B; Mohammad AK; Dimovski R; Cassio FL; Bazito RC; Conti D; Fu Q; Reineke J; da Rocha SR
Mol Pharm; 2015 Mar; 12(3):826-38. PubMed ID: 25455560
[TBL] [Abstract][Full Text] [Related]
4. Poly(amidoamine) Dendrimer-Doxorubicin Conjugates: In Vitro Characteristics and Pseudosolution Formulation in Pressurized Metered-Dose Inhalers.
Zhong Q; da Rocha SR
Mol Pharm; 2016 Mar; 13(3):1058-72. PubMed ID: 26832992
[TBL] [Abstract][Full Text] [Related]
5. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
6. Polymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblends.
Bharatwaj B; Dimovski R; Conti DS; da Rocha SR
AAPS J; 2014 May; 16(3):522-38. PubMed ID: 24691741
[TBL] [Abstract][Full Text] [Related]
7. Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.
Zhong Q; Merkel OM; Reineke JJ; da Rocha SR
Mol Pharm; 2016 Jun; 13(6):1866-78. PubMed ID: 27148629
[TBL] [Abstract][Full Text] [Related]
8. Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium.
Conti DS; Brewer D; Grashik J; Avasarala S; da Rocha SR
Mol Pharm; 2014 Jun; 11(6):1808-22. PubMed ID: 24811243
[TBL] [Abstract][Full Text] [Related]
9. Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery.
Sweet DM; Kolhatkar RB; Ray A; Swaan P; Ghandehari H
J Control Release; 2009 Aug; 138(1):78-85. PubMed ID: 19393702
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of pH-Responsive, PEG-Doxorubicin Conjugates: Interaction with an in Vitro Model of Lung Adenocarcinoma and Their Direct Formulation in Propellant-Based Portable Inhalers.
Rao KSVK; Zhong Q; Bielski ER; da Rocha SRP
Mol Pharm; 2017 Nov; 14(11):3866-3878. PubMed ID: 28972765
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biodistribution, and imaging of PEGylated-acetylated polyamidoamine dendrimers.
Liu J; Liu J; Chu L; Tong L; Gao H; Yang C; Wang D; Shi L; Kong D; Li Z
J Nanosci Nanotechnol; 2014 May; 14(5):3305-12. PubMed ID: 24734545
[TBL] [Abstract][Full Text] [Related]
12. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia.
Santos SD; Xavier M; Leite DM; Moreira DA; Custódio B; Torrado M; Castro R; Leiro V; Rodrigues J; Tomás H; Pêgo AP
J Control Release; 2018 Dec; 291():65-79. PubMed ID: 30308255
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.
Kojima C; Turkbey B; Ogawa M; Bernardo M; Regino CA; Bryant LH; Choyke PL; Kono K; Kobayashi H
Nanomedicine; 2011 Dec; 7(6):1001-8. PubMed ID: 21515406
[TBL] [Abstract][Full Text] [Related]
14. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent.
Ryan GM; Kaminskas LM; Kelly BD; Owen DJ; McIntosh MP; Porter CJ
Mol Pharm; 2013 Aug; 10(8):2986-95. PubMed ID: 23750747
[TBL] [Abstract][Full Text] [Related]
16. PEGylated, NH2-terminated PAMAM dendrimers: a microscopic view from atomistic computer simulations.
Yang L; da Rocha SR
Mol Pharm; 2014 May; 11(5):1459-70. PubMed ID: 24679335
[TBL] [Abstract][Full Text] [Related]
17. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
[TBL] [Abstract][Full Text] [Related]
18. PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.
Zhu S; Hong M; Zhang L; Tang G; Jiang Y; Pei Y
Pharm Res; 2010 Jan; 27(1):161-74. PubMed ID: 19862607
[TBL] [Abstract][Full Text] [Related]
19. Propellant-based inhalers for the non-invasive delivery of genes via oral inhalation.
Conti DS; Bharatwaj B; Brewer D; da Rocha SR
J Control Release; 2012 Feb; 157(3):406-17. PubMed ID: 21982899
[TBL] [Abstract][Full Text] [Related]
20. Stealth dendrimers for drug delivery: correlation between PEGylation, cytocompatibility, and drug payload.
Yang H; Lopina ST; DiPersio LP; Schmidt SP
J Mater Sci Mater Med; 2008 May; 19(5):1991-7. PubMed ID: 17952565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
